BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20190101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201103
DTEND;VALUE=DATE:20201106
DTSTAMP:20260515T132356
CREATED:20200803T075703Z
LAST-MODIFIED:20200803T094758Z
UID:26593-1604361600-1604620799@www.pharmajournalist.com
SUMMARY:Digital 5th Neoantigen Based Therapies Summit
DESCRIPTION:With all eyes on the explosive neoantigen field watching to see how it can revolutionize cancer immunotherapies and rival the current T cell therapies\, it is clear that critical questions still remain to be addressed to ensure full therapeutic success. \n \nTaking place from the comfort of your own home this year\, the 5th Neoantigen Based Therapies Summit remains the only industry focused meeting dedicated to the full end-to-end development and commercialization of neoantigen-based cancer immunotherapies. \nView the full event guide for more details on this content packed 3-day virtual event. \nWe’ll be addressing the most pressing challenges in the field\, including: \n\nIdentifying both personalized and shared Neoantigens to supercharge development of next generation immunotherapy with University of Miami and Netherlands Cancer Institute\nImproving prediction accuracy by exploring different neoantigen sources with Ervaxx\, Precision Biologics and Broad Institute\nHow to maximize immunogenicity to drive clinical development & success with Gritstone Oncology\, Genocea and Treos Bio\nReducing complex process and release times by navigating through complex manufacturing challenges with Achilles Therapeutics\, Vaximm and ISA Therapeutics\n\nDownload the official brochure to see what sessions will help you to advance your cancer immunotherapy pipeline. \nJoin us online to gain the practical insights you need to improve the immune response and commercial viability of your neoantigen based cancer immunotherapy.
URL:https://www.pharmajournalist.com/event/digital-5th-neoantigen-based-therapies-summit/
LOCATION:Online | Digital Event
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201105
DTEND;VALUE=DATE:20201107
DTSTAMP:20260515T132356
CREATED:20200422T104308Z
LAST-MODIFIED:20200605T111205Z
UID:25191-1604534400-1604707199@www.pharmajournalist.com
SUMMARY:8th Microbiome R&D & Business Collaboration Forum: USA
DESCRIPTION:This forum has a long-standing reputation for bringing together leading academic and industry microbiome researchers. Presentations will feature the latest research into the human microbiome as well as effective business and commercialization strategies for new products. \n \nTopics covered on the agenda include: \n\nIBD\, Colitis\, and Metabolic Diseases\nGut-brain axis\nWomen’s health\nSkin & Cosmeceuticals\nPersonalized nutrition\nBusiness Collaboration – Regulations & Investment\nProbiotics & Prebiotics\nRoundtable discussions\n\nWith dedicated space in the schedule to network\, this conference is the ideal forum to share knowledge and build partnerships. \nVisit the event page to download the full agenda.
URL:https://www.pharmajournalist.com/event/8th-microbiome-rd-business-collaboration-forum-usa/
LOCATION:San Diego\, USA
ORGANIZER;CN="Global Engage Ltd.":MAILTO:info@globalengage.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201105
DTEND;VALUE=DATE:20201107
DTSTAMP:20260515T132356
CREATED:20200422T105422Z
LAST-MODIFIED:20200605T110713Z
UID:25195-1604534400-1604707199@www.pharmajournalist.com
SUMMARY:2nd Skin Microbiome & Cosmeceuticals Congress: USA
DESCRIPTION:This congress will explore the burgeoning field of skin microbiome research\, with case studies focused on topics such atopic dermatitis\, psoriasis\, acne\, and allergy\, and the microbiome-based products being developed to fight these diseases. The conference also provided insight into the future of microbiome-based cosmetics\, with numerous presentations given on trial design\, commercial strategy\, and consumer awareness and expectations. \nWith dedicated space in the schedule to network\, this conference is the ideal forum to share knowledge and build partnerships. \nVisit the event page to download the full agenda.
URL:https://www.pharmajournalist.com/event/2nd-skin-microbiome-cosmeceuticals-congress-usa/
LOCATION:San Diego\, USA
ORGANIZER;CN="Global Engage Ltd.":MAILTO:info@globalengage.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201105
DTEND;VALUE=DATE:20201107
DTSTAMP:20260515T132356
CREATED:20200422T133821Z
LAST-MODIFIED:20200605T111031Z
UID:25202-1604534400-1604707199@www.pharmajournalist.com
SUMMARY:5th Probiotics & Prebiotics Congress: USA
DESCRIPTION:This Congress will include numerous presentations on probiotics discovery and product development\, as well as prebiotics\, diet and nutrition. Alongside several case studies on digestive health\, metabolic diseases\, ageing and allergy\, the conference highlighted the importance of the early life microbiome\, the milk microbiome\, and the use of probiotics to modulate the infant gut. \nWith dedicated space in the schedule to network\, this conference is the ideal forum to share knowledge and build partnerships. \nVisit the event page to download the full agenda. \n 
URL:https://www.pharmajournalist.com/event/5th-probiotics-prebiotics-congress-usa/
LOCATION:San Diego\, USA
ORGANIZER;CN="Global Engage Ltd.":MAILTO:info@globalengage.co.uk
END:VEVENT
END:VCALENDAR